Beigene Ltd (BGNE)

Beigene Ltd (BGNE)


Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Beigene Ltd (BGNE) Profile

Beigene Ltd (ADRs) (BGNE.xnas) is a biotechnology company headquartered in Beijing, China. Beigene specialises in the development of drugs for cancer treatment. Its products include tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton’s tyrosine kinase inhibitor, which became the 1st cancer drug developed in China to gain approval from the U.S Food and Drug Administration. Beigene has offices in China, Australia, the United States and Europe and employs approximately 3,500 people worldwide. Beigene Ltd stock is listed on the NASDAQ and had a market capitalisation of $26.59B (USD) as of January 2022 and $1.11B (USD) in 2021 yearly revenues. At the end of 2021, the company announced an option, collaboration and licence agreement with Novartis Pharma AG to develop, manufacture and commercialise Beigene’s investigational TIGIT inhibitor ociperlimab in Europe, North America, and Japan. Additionally, both companies entered into an agreement granting Beigene rights to market, promote and detail five approved Novartis oncology products across designated regions of China. The European Commission (EC) approved Beigene’s drug BRUKINSA to treat adult patients with Waldenstrom’s macroglobulinemia (WM).

Holding cost
Largos
-5%
Cortos
-2.5%
Trading hours in US Eastern Time
Fri
16:30-23:00
Mon
16:30-23:00
Tue
16:30-23:00
Wed
16:30-23:00
Thu
16:30-23:00
Sun
Cierra
Sat
Cierra

Start Trading Beigene Ltd (BGNE)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as acciones, commodities, y foreign exchange, y índices.

6 razones para operar CFD sobre acciones con FP Markets

Regulado en Australia
Bróker de forex y CFD

A largo o a corto

Increase your ability to profit in all market conditions Leverage options up to 20:1

Ejecución DMA
(Acceso directo al mercado)

Precios de acciones transparentes
y en tiempo real Control, funcionalidad y liquidez abundante
Total profundidad de mercado
y vista de órdenes en la cola

Plataformas avanzadas
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

Soporte multilingüe 24/7

Award winning support & personal account managers

Exposición global

Márgenes bajos y comisiones competitivas en +10.000 productos en acciones globales en cuatro continentes

Gana dividendos

On long positions No ownership of physical shares necessary

Empieza a hacer trading
en cuestión de minutos.

Abre una cuenta ahora

bullet Accede a más de 10.000 instrumentos financieros
bullet Apertura y cierre automático de posiciones
bullet Noticias y agenda económica
bullet Indicadores técnicos y gráficos
bullet Muchas más herramientas incluidas

Al proporcionar su correo electrónico, usted acepta la política de privacidad de FP Markets y está de acuerdo en recibir futuros mensajes de marketing por parte de FP Markets. Puede darse de baja en cualquier momento.





Get instant Updates in Telegram
Mapa del sitio | © FP Markets 2022